These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 25921139)
21. HOXA10 is overexpressed in human ovarian clear cell adenocarcinoma and correlates with poor survival. Li B; Jin H; Yu Y; Gu C; Zhou X; Zhao N; Feng Y Int J Gynecol Cancer; 2009 Nov; 19(8):1347-52. PubMed ID: 20009888 [TBL] [Abstract][Full Text] [Related]
22. Increased expression of the RIalpha subunit of the cAMP-dependent protein kinase A is associated with advanced stage ovarian cancer. McDaid HM; Cairns MT; Atkinson RJ; McAleer S; Harkin DP; Gilmore P; Johnston PG Br J Cancer; 1999 Feb; 79(5-6):933-9. PubMed ID: 10070893 [TBL] [Abstract][Full Text] [Related]
23. ELF5 in epithelial ovarian carcinoma tissues and biological behavior in ovarian carcinoma cells. Yan H; Qiu L; Xie X; Yang H; Liu Y; Lin X; Huang H Oncol Rep; 2017 Mar; 37(3):1412-1418. PubMed ID: 28184931 [TBL] [Abstract][Full Text] [Related]
24. MiR-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3. Chang W; Liu M; Xu J; Fu H; Zhou B; Yuan T; Chen P Tumour Biol; 2016 Nov; 37(11):14813-14824. PubMed ID: 27638830 [TBL] [Abstract][Full Text] [Related]
25. Thrombospondin-1 and -2 messenger RNA expression in epithelial ovarian tumor. Kodama J; Hashimoto I; Seki N; Hongo A; Yoshinouchi M; Okuda H; Kudo T Anticancer Res; 2001; 21(4B):2983-7. PubMed ID: 11712798 [TBL] [Abstract][Full Text] [Related]
26. Ikaros inhibits proliferation and, through upregulation of Slug, increases metastatic ability of ovarian serous adenocarcinoma cells. He LC; Gao FH; Xu HZ; Zhao S; Ma CM; Li J; Zhang S; Wu YL Oncol Rep; 2012 Oct; 28(4):1399-405. PubMed ID: 22859015 [TBL] [Abstract][Full Text] [Related]
27. [Expression and clinical significance of endostatin and vascular endothelial growth factor in ovarian carcinoma]. Shi HR; Song WJ; Chen ZM; Wu QH Ai Zheng; 2005 Sep; 24(9):1127-31. PubMed ID: 16159439 [TBL] [Abstract][Full Text] [Related]
28. p70 S6 kinase promotes epithelial to mesenchymal transition through snail induction in ovarian cancer cells. Pon YL; Zhou HY; Cheung AN; Ngan HY; Wong AS Cancer Res; 2008 Aug; 68(16):6524-32. PubMed ID: 18701475 [TBL] [Abstract][Full Text] [Related]
29. Expression of the endothelial cell differentiation gene 7 (EDG-7), a lysophosphatidic acid receptor, in ovarian tumor. Nakamoto T; Yasuda K; Yasuhara M; Yoshimura T; Kinoshita T; Nakajima T; Okada H; Ikuta A; Kanzaki H J Obstet Gynaecol Res; 2005 Aug; 31(4):344-51. PubMed ID: 16018784 [TBL] [Abstract][Full Text] [Related]
30. Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target. Fejzo MS; Dering J; Ginther C; Anderson L; Ramos L; Walsh C; Karlan B; Slamon DJ Genes Chromosomes Cancer; 2008 Oct; 47(10):873-83. PubMed ID: 18615678 [TBL] [Abstract][Full Text] [Related]
31. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer. Shigemasa K; Tian X; Gu L; Tanimoto H; Underwood LJ; O'Brien TJ; Ohama K Oncol Rep; 2004 Jun; 11(6):1153-9. PubMed ID: 15138549 [TBL] [Abstract][Full Text] [Related]
32. p21WAF1/CIP1 protein expression in primary ovarian cancer. Ferrandina G; Stoler A; Fagotti A; Fanfani F; Sacco R; De Pasqua A; Mancuso S; Scambia G Int J Oncol; 2000 Dec; 17(6):1231-5. PubMed ID: 11078810 [TBL] [Abstract][Full Text] [Related]
33. A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer. Nagaraja AK; Creighton CJ; Yu Z; Zhu H; Gunaratne PH; Reid JG; Olokpa E; Itamochi H; Ueno NT; Hawkins SM; Anderson ML; Matzuk MM Mol Endocrinol; 2010 Feb; 24(2):447-63. PubMed ID: 20081105 [TBL] [Abstract][Full Text] [Related]
34. A novel regulatory mechanism of Pim-3 kinase stability and its involvement in pancreatic cancer progression. Zhang F; Liu B; Wang Z; Yu XJ; Ni QX; Yang WT; Mukaida N; Li YY Mol Cancer Res; 2013 Dec; 11(12):1508-20. PubMed ID: 24165482 [TBL] [Abstract][Full Text] [Related]
35. RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer. Bignone PA; Lee KY; Liu Y; Emilion G; Finch J; Soosay AE; Charnock FM; Beck S; Dunham I; Mungall AJ; Ganesan TS Oncogene; 2007 Feb; 26(5):683-700. PubMed ID: 16878154 [TBL] [Abstract][Full Text] [Related]
36. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients. Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906 [TBL] [Abstract][Full Text] [Related]
37. Cell cycle-related kinase supports ovarian carcinoma cell proliferation via regulation of cyclin D1 and is a predictor of outcome in patients with ovarian carcinoma. Wu GQ; Xie D; Yang GF; Liao YJ; Mai SJ; Deng HX; Sze J; Guan XY; Zeng YX; Lin MC; Kung HF Int J Cancer; 2009 Dec; 125(11):2631-42. PubMed ID: 19672860 [TBL] [Abstract][Full Text] [Related]
38. [Expression of hSef and FGF-2 in epithelial ovarian tumor]. Feng QL; Shi HR; Qiao LJ; Zhao J Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):770-4. PubMed ID: 22335910 [TBL] [Abstract][Full Text] [Related]
39. [Study on the expression of the gene deleted in colorectal carcinoma in ovarian carcinoma]. Li PL; Liu MM; Ni J Zhonghua Fu Chan Ke Za Zhi; 2003 Apr; 38(4):207-9. PubMed ID: 12885365 [TBL] [Abstract][Full Text] [Related]
40. [Human pituitary tumor transforming gene 1 expression in ovarian carcinoma and its clinical significance]. Cheng YX; Feng J; Zhang XY; Fu TY; Yao Y Ai Zheng; 2004 Sep; 23(9):1026-30. PubMed ID: 15363195 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]